EarlySense debuts contact-free fertility tracker

EarlySense's Percept system captures the body's "internal signals" to help women track their fertility window. (EarlySense)

EarlySense, known for its under-the-mattress vital sign monitoring system, is launching a similar device, but for fertility tracking.

Placed under a user’s mattress, the Percept system captures the body’s “internal signals” and provide the user with information and predictions on their ovulation, menstruation, sleep patterns, vital signs and stress levels, EarlySense said in a statement.

The device learns a user’s menstrual cycle and fertility window, the company said, and it only gets more accurate with time. It uses Bluetooth to connect to a smartphone app, where users may view a calendar of their menstrual and ovulation cycles, as well as daily tips.


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

RELATED: Israeli startup EarlySense nabs $25M to back contact-free continuous patient monitoring

The contact-free device is an alternative to a number of methods that women currently use to track their fertility, including measuring basal body temperature or wearing a patch, EarlySense said.

"With today's busy and hectic lifestyles, women want more readily available data to control their fertility. The need has translated into millions of downloads of period-tracking apps. However, despite this uptick in app downloads—fully convenient, medically-proven and accurate solutions had yet to be created," said CEO Avner Halperin, in the statement. "Knowing this, EarlySense is providing the world's first practically effortless and extremely accurate fertility tracker.”

EarlySense markets a number of contact-free patient monitoring devices, including systems for hospital use and home use. Its namesake EarlySense system tracks a patient’s heart rate, respiratory rate and movement via the under-the-mattress sensor. This data is continuously displayed on a bedside monitor and at nurse stations.

RELATED: Ava bags $10M for wrist-worn fertility tracker

In September last year, the company launched its InSight platform, a modified version of its system for post-acute care settings, including nursing or rehabilitation facilities. The InSight system is tweaked to help clinicians in these settings achieve their two main outcomes: reducing rehospitalizations and preventing falls.

Suggested Articles

The FDA has cleared Drawbridge Health’s blood collection device designed to help monitor long-term blood sugar levels in people with diabetes.

Rachel Humphrey, M.D., who joined CytomX as chief medical officer after heading immuno-oncology at AstraZeneca and Eli Lilly, has made her exit.

FierceMedTech Fierce 15 winner 10x Genomics announced its plans for a $100 million IPO, on the Nasdaq using the symbol TXG.